Tokio Marine Asset Management’s Royalty Pharma RPRX Stock Holding History

Tokio Marine Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.18M	Buy	20,969 +4,422	+27%	+$230K	0.04%	362
2026 Q1	$794K	Buy	16,547 +2,452	+17%	+$107K	0.03%	409
2025 Q4	$545K	Buy	14,095 +96	+0.7%	+$3.66K	0.02%	483
2025 Q3	$494K	Buy	13,999 +1,000	+8%	+$36.2K	0.02%	495
2025 Q2	$468K	Buy	12,999 +956	+8%	+$31.7K	0.02%	494
2025 Q1	$375K	Buy	12,043 +2,946	+32%	+$93.4K	0.01%	529
2024 Q4	$232K	Hold	9,097	–	–	0.01%	571
2024 Q3	$257K	Hold	9,097	–	–	0.01%	552
2024 Q2	$240K	Hold	9,097	–	–	0.01%	549
2024 Q1	$276K	Buy	9,097 +887	+11%	+$26.1K	0.01%	542
2023 Q4	$231K	Hold	8,210	–	–	0.01%	543
2023 Q3	$223K	Buy	8,210 +607	+8%	+$18K	0.01%	542
2023 Q2	$234K	Buy	7,603 +914	+14%	+$31K	0.01%	533
2023 Q1	$241K	Buy	6,689 +1,531	+30%	+$56.8K	0.02%	513
2022 Q4	$204K	Hold	5,158	–	–	0.02%	526
2022 Q3	$207K	Hold	5,158	–	–	0.02%	483
2022 Q2	$217K	Buy	+5,158	New	+$211K	0.02%	465

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tokio Marine Asset Management's RPRX Position: Q2 2026 in Review

Tokio Marine Asset Management increased its Royalty Pharma (RPRX) stake by 27% in Q2 2026, buying an estimated $230K and bringing the position to 20,969 shares worth $1.18M. The position accounts for 0.04% of the portfolio, ranked #362.

Tokio Marine Asset Management first reported a position in RPRX in Q2 2022 and has held it in 17 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Tokio Marine Asset Management held 20,969 shares of Royalty Pharma worth $1.18M as of Q2 2026.
Tokio Marine Asset Management bought 4,422 Royalty Pharma shares in Q2 2026, an estimated $230K.
Royalty Pharma made up 0.04% of Tokio Marine Asset Management's portfolio in Q2 2026, its #362 holding.
Tokio Marine Asset Management first reported a position in Royalty Pharma in Q2 2022 and has held it in 17 quarters since.
641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Tokio Marine Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.